Platelet Rich Plasma Market, By Type (Pure PRP, Leukocyte rich PRP, Pure PRF, Leukocyte rich PRF), By Origin (Autologous, Allogenic, Homologues), By Application (Neurosurgery, Cosmetic Surgery, Orthopedic Surgery, General Surgery, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
Platelet rich plasma (PRP) is a portion of the plasma fraction of analogous blood, which contains platelet concentration more than standard concentration. Platelets contains bio proteins that helps in healing, tissue regeneration, and blood loss. Platelet rich plasma protein consists of three proteins, which acts as cell adhesive molecules that are fibrin, fibronectin, and vitronectin. The use of platelet rich plasma therapy is tremendously increased after 2009 due to its wide application and no side effects. Platelet rich plasma is used for the treatment of injured tendons, muscle, joints, and ligaments. Use of PRP therapy on patients with low back pain helps them to recover. It is also widely used for the treatment for baldness, as PRP treatment increase the blood flow. In turn supporting the hair growth.
Restraints of the Global Platelet Rich Plasma Market
Major factors hampering the growth of the platelet rich plasma market during the forecast period constitutes of uncertainty about therapeutic efficacy of platelet-rich plasma.
Key features of the study:
This report provides in-depth analysis of the global platelet rich plasma market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global platelet rich plasma market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Arthrex, Inc., Stryker Corporation, Johnson and Johnsons Ltd., Zimmer Biomet Holdings Inc., Terumo Corporation, Glofinn Oy, Medira Ltd., Regen Lab S.A., CollPlant, Generex Biotechnology Corporation, and Estar Technologies Ltd
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global platelet rich plasma market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
Detailed Segmentation
Global Platelet Rich Plasma Market, By Type:
Pure PRP
Leukocyte rich PRP
Pure PRF
Leukocyte rich PRF
Global Platelet Rich Plasma Market, By Origin:
Autologous
Allogenic
Homologues
Global Platelet Rich Plasma Market, By Application:
Neurosurgery
Cosmetic Surgery
Orthopedic Surgery
General Surgery
Others
Global Platelet Rich Plasma Market, By Geography:
North America
By Type
Pure PRP
Leukocyte rich PRP
Pure PRF
Leukocyte rich PRF
By Origin
Autologous
Allogenic
Homologues
By Application
Neurosurgery
Cosmetic Surgery
Orthopedic Surgery
General Surgery
Others
By Country:
U.S.
Canada
Europe
By Type
Pure PRP
Leukocyte rich PRP
Pure PRF
Leukocyte rich PRF
By Origin
Autologous
Allogenic
Homologues
By Application
Neurosurgery
Cosmetic Surgery
Orthopedic Surgery
General Surgery
Others
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Type
Pure PRP
Leukocyte rich PRP
Pure PRF
Leukocyte rich PRF
By Origin
Autologous
Allogenic
Homologues
By Application
Neurosurgery
Cosmetic Surgery
Orthopedic Surgery
General Surgery
Others
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
By Type
Pure PRP
Leukocyte rich PRP
Pure PRF
Leukocyte rich PRF
By Origin
Autologous
Allogenic
Homologues
By Application
Neurosurgery
Cosmetic Surgery
Orthopedic Surgery
General Surgery
Others
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Middle East:
By Type
Pure PRP
Leukocyte rich PRP
Pure PRF
Leukocyte rich PRF
By Origin
Autologous
Allogenic
Homologues
By Application
Neurosurgery
Cosmetic Surgery
Orthopedic Surgery
General Surgery
Others
By Country:
GCC
Israel
Rest of Middle East
Africa
By Type
Pure PRP
Leukocyte rich PRP
Pure PRF
Leukocyte rich PRF
By Origin
Autologous
Allogenic
Homologues
By Application
Neurosurgery
Cosmetic Surgery
Orthopedic Surgery
General Surgery
Others
By Country/Region:
Central Africa
South Africa
North Africa
Company Profiles
Arthrex, Inc.*
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Stryker Corporation
Johnson and Johnsons Ltd.
Zimmer Biomet Holdings Inc.
Terumo Corporation
Glofinn Oy
Medira Ltd.
Regen Lab S.A.
CollPlant
Generex Biotechnology Corporation
Estar Technologies Ltd.
“*” marked represents similar segmentation in other categories in the respective section.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook